Adrian von Witzleben

8PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyPopulation trends and policiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 19, 2026
Transcriptomic Profiling of Cutaneous Melanoma Metastases Treated With Microwave Ablation-Pilot Study.

|Feb 08, 2024
INHBA is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression.

Tsima Abou Kors, Linda Hofmann, Annika Betzler

|Oct 24, 2023
Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103-CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease.

Adrian von Witzleben, Matthew Ellis, Gareth J Thomas

|May 04, 2022
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs.

Simon Eschweiler, Ciro Ramírez-Suástegui, Yingcong Li

|Mar 06, 2021
Increasing Mean Age of Head and Neck Cancer Patients at a German Tertiary Referral Center.

Julius M Vahl, Marlene C Wigand, Michael Denkinger

|Dec 18, 2020
Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC).

Adrian von Witzleben, Adrian Fehn, Ayla Grages

Pageof 2

Frequent Collaborators

6 joint publications

Simon Laban

6 joint publications

Christian Ottensmeier

4 joint publications

Cornelia Brunner

4 joint publications

Patrick J Schuler